Clinical science| Volume 202, ISSUE 2, P127-132, August 2011

Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions

Published:February 08, 2011DOI:



      Percutaneous needle biopsy, also known as minimally invasive breast biopsy (MIBB), has become the gold standard for the initial assessment of suspicious breast lesions. The purpose of this study is to determine modern rates of MIBB and open breast biopsy.


      The Florida Agency for Health Care Administration outpatient surgery and procedure database was queried for patients undergoing open surgical biopsy and MIBB between 2003 and 2008.


      Although there was an increase in the use of MIBB, the overall rate of open surgical biopsy remained high (∼30%). A reduction in the open biopsy rate from 30% to 10% could be associated with a charge reduction of >$37.2 million per year.


      The current rate of open surgical breast biopsy remains high. Interventions and quality initiatives are warranted, which could lead to a reduction in unnecessary operations for women, improved patient care, and a reduction in breast health care costs.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Silverstein M.J.
        • Recht A.
        • Lagios M.D.
        • et al.
        Special report: consensus conference III.
        J Am Coll Surg. 2009; 209: 504-520
        • Silverstein M.J.
        • Lagios M.D.
        • Recht A.
        • et al.
        Image-detected breast cancer: state of the art diagnosis and treatment.
        J Am Coll Surg. 2005; 201: 586-597
        • American Society of Breast Surgeons
        Official consensus statement of percutaneous needle biopsy for image detected breast abnormalities.
        (Accessed December 5, 2006)
        • Lind D.S.
        • Minter R.
        • Steinbach B.
        • et al.
        Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer.
        J Surg Res. 1998; 78: 23-26
        • Clarke-Pearson E.M.
        • Jacobson A.F.
        • Boolbol S.K.
        • et al.
        Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique.
        J Am Coll Surg. 2009; 208: 75-78
        • Silverstein M.
        Where's the outrage?.
        J Am Coll Surg. 2009; 208: 78-79
      1. Edge SB, Ottesen RA, Lepisto EM, et al. Surgical biopsy to diagnose breast cancer adversely affects outcomes of breast cancer care: finding from the National Comprehensive Cancer Network. Presented at: San Antonio Breast Cancer Symposium; San Antonio, TX; 2005.

        • Florida Agency for Health Care Administration
        (Home page) (Accessed February 23, 2010)
        • Florida Agency for Health Care Administration
        (Accessed February 23, 2010)
        • Witmer M.T.
        • Margo C.E.
        Analysis of ophthalmology workforce and delivery of emergency department eye care in Florida.
        Arch Ophthalmol. 2009; 127: 1522-1527
        • Armitage P.
        Tests for linear trends in proportions and frequencies.
        Biometrics. 1955; 11: 375-386
        • Bruening W.
        • Schoelles K.
        • Treadwell J.
        Comparative effectiveness of core-needle biopsies and open surgical biopsy for the diagnosis of breast lesions.
        Agency for Healthcare Research and Quality, Rockville, MD2009
        • Friese C.R.
        • Neville B.A.
        • Edge S.B.
        • et al.
        Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data.
        Cancer. 2009; 115: 716-724
        • Silverstein M.
        • Levine G.M.
        Reply to: “Minimally invasive breast biopsy.”.
        J Am Coll Surg. 2009; 209: 289
        • Paajanen H.
        • Hermunen H.
        Does preoperative core needle biopsy increase surgical site infections in breast cancer surgery?.
        Surg Infect (Larchmt). 2009; 10: 317-321